Jim Lanter, PhD, Vice President, Medicinal Chemistry

Jim works closely with external chemistry groups spanning two continents to bring Arkuda’s drug discovery visions to life. Like most medicinal chemists, Jim’s aspiration is to invent new medicines that have a true and meaningful impact on patients’ lives. He’s particularly interested in addressing the root causes of neurodegeneration to bring relief to affected individuals and their families.

Jim has over two decades of expertise in applying his knowledge of synthetic organic chemistry to nearly all areas of medicine. Over the course of his career he’s had the opportunity to work on a broad range of drugs classes, including small molecules, peptides and protein therapeutics.